Member overview

myriamed GmbH

Separating the pharmacological wheat from the chaff is the primary goal of myriamed. Our proprietary human cell and engineered tissue models allow for the simulation of health and disease in the dish. Our platform technologies find broad applications in early stages of drug discovery and refinement of the most promising therapeutic candidates.

Information gained from our advanced engineered tissue models can assist drug developers in defining safe and effective doses for first in human studies. Reduction in attrition rate and acceleration of clinical translation of the most promising therapeutic candidates to address pressing unmet medical needs is what we strive for.

Contact

Please contact us for further information:

Dr. Wolf Jokusch

Managing Director

contact@myriamed.com

+4955128878170